January 11, 2024
Sapio’s unified LIMS and ELN platform for research and clinical informatics has been validated for use in labs that follow "good practice" (GMP, GLP, and GCP) quality guidelines and regulations BALTIMORE -- Sapio Sciences, the science-aware™ lab informatics platform, today announced that its unified platform for research and clinical informatics has been validated to comply with [...]
January 11, 2024
PARIS, France – Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its [...]
January 11, 2024
The AccuSignal™ Nuclease ELISA Kit is designed to detect any Serratia marcescens endonuclease, such as Benzonase®, DENARASE®, and Turbonuclease, to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more. LIMERICK, Pa.— For over 60 years, Rockland has been providing antibodies, assays, and supporting reagents to accurately reflect the quality of biopharmaceutical products [...]
ChromaCode Announces Appointment of Mark McDonough as Chairman
January 10, 2024
CARLSBAD, Calif. -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, announces Mark McDonough as Chair of the Board, the retirement of former Chair Carol Gallagher, Pharm.D., and the appointment of Michele Park, Ph.D. to the Board. Mark McDonough, CEO of ChromaCode, becomes Chair of the Board, effective January 1, 2024. Retiring Chair, Carol Gallagher commented, [...]
Oxford Instruments acquires First Light Imaging SAS
January 10, 2024
Oxford Instruments plc (“the Group”, “Oxford Instruments”), a leading provider of high technology products and services to industry and scientific research communities, today announces the acquisition of First Light Imaging SAS (“First Light”), a scientific camera specialist. Based near Aix-en-Provence, France, and founded in 2011, First Light specialises in the design and manufacture of high-speed, [...]
January 10, 2024
Leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational, clinical, and diagnostic applications of Akoya’s spatial biology solutions MARLBOROUGH, Mass. -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced the establishment of its Scientific Advisory Board (SAB) to provide strategic guidance and consult on the Company's efforts to [...]
QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development
January 10, 2024
NEWARK, Delaware -- QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics in Europe. QPS announces an expanded and upgraded fleet of mass spectrometers, with the addition of a new TripleTOF® 6600+ for GLP [...]
January 10, 2024
Life science researchers can use DNAnexus’ Precision Health Data Cloud to analyze high-value omics data and quickly gain insights that pave the way for innovative discoveries MOUNTAIN VIEW, Calif., & PORTLAND, Maine -- DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Ovation, an omics data company committed to accelerating the development of precision [...]
Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders
January 9, 2024
Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives Cambridge, UK: Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies (CGTs), has today announced the formation of its [...]
January 9, 2024
New collaborative research center based at University of California, Berkeley, plans to develop platform approaches that can be easily modified to develop gene-editing medicines for hundreds of devastating illnesses Innovative model aims to dramatically reduce preclinical and clinical development time and expense for investigational rare disease therapies that currently struggle to attract funding Nobel laureate Doudna [...]

